Substance Use Disorder, Intravenous Injection, and HIV Infection: A Review

Shao Cheng Wang, Brion Maher

Research output: Contribution to journalReview articlepeer-review

Abstract

DSM-V-defined substance use disorder comprises four groups of symptoms: impaired control, social impairment, risky use, and pharmacological reactions. Behavioral patterns of impaired control, including impulsivity and risk taking, are associated with HIV risk behaviors. Substance users with stronger craving symptoms are more likely to use drugs via intravenous injection than other routes because of the faster drug effect and the higher bioavailability; thus, they are at high risk of HIV infection. HIV risk behaviors such as unprotected sex and intravenous injection facilitate HIV disease spread. Public health policies such as Needle and Syringe Exchange Programs and medication-assisted treatment are proven to reduce HIV risk behaviors such as the frequency of intravenous injection and even the incidence of HIV infection, but both of them have limitations. While intravenous injection is a frequently discussed issue in public policies and the HIV-related literature, it is a much less frequent topic in the addiction literature. We believed that understanding the mental substrate behind impulsivity/risk taking and the possible biological mechanism of intravenous injection may help in creating more effective strategies to slow down HIV infection.

Original languageEnglish (US)
Pages (from-to)1465-1471
Number of pages7
JournalCell Transplantation
Volume28
Issue number12
DOIs
StatePublished - Dec 1 2019

Keywords

  • HIV risk behavior
  • intravenous drug injection
  • substance use disorder

ASJC Scopus subject areas

  • Biomedical Engineering
  • Cell Biology
  • Transplantation

Fingerprint Dive into the research topics of 'Substance Use Disorder, Intravenous Injection, and HIV Infection: A Review'. Together they form a unique fingerprint.

Cite this